Mixed secondary bacterial infection is associated with severe lesions of chromoblastomycosis in a neglected population from Brazil

Diagn Microbiol Infect Dis. 2019 Oct;95(2):201-207. doi: 10.1016/j.diagmicrobio.2019.05.018. Epub 2019 May 31.

Abstract

Chromoblastomycosis (CBM) is a chronic subcutaneous infection caused by melanotic fungi, affecting mainly rural workers in tropical and subtropical regions. Secondary bacterial infections (SBIs) in CBM lesions bring complications to the disease, but little is known about the agents involved. Fungal and bacterial identification and epidemiological profile of 50 patients with CBM were analyzed in this study. Bacteria were tested for susceptibility to antibacterial drugs. Fonseacea pedrosoi and Rhinocladiella aquaspersa were the fungal agents isolated. 88% of the patients presented SBI. Gram-positive bacteria coinfected mainly upper limbs, and Gram-negative bacteria were more isolated from lower limbs. Streptococcus pyogenes and mixed bacterial microbiota were associated with severe lesions. Staphylococcus aureus was associated with mixed infections and consequently with the severity of the infection. Resistance to β-lactams and methicillin was detected. Our results emphasize the necessity of bacterial culture and susceptibility testing as part of routine monitoring CBM cases.

Keywords: Antimicrobial susceptibility; Chromoblastomycosis; Microbiota; Mixed; Secondary infection.

MeSH terms

  • Aged
  • Anti-Bacterial Agents / pharmacology
  • Ascomycota / isolation & purification
  • Bacteria / classification
  • Bacteria / drug effects
  • Bacteria / isolation & purification
  • Brazil / epidemiology
  • Chromoblastomycosis / diagnosis
  • Chromoblastomycosis / epidemiology
  • Chromoblastomycosis / microbiology*
  • Coinfection / diagnosis
  • Coinfection / epidemiology
  • Coinfection / microbiology*
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Microbiota
  • Middle Aged
  • Species Specificity

Substances

  • Anti-Bacterial Agents